Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic (TeleCoviDiab)

University Hospital, Strasbourg, France

Status: Completed

Conditions: Diabetes; Covid-19

Treatments: Other: care modalities; Other: Teleconsultation either by phone or by computer consultation

Study type: Observational

Funder types: Other

Identifiers

NCT04370171

7775

Details and patient eligibility

About

Since the end of February 2020, Covid-19 infection has spread widely in France, particularly in the East region, with on March 25th, 2020, 5,479 infected patients and 407 deceased patients, including 256 in Alsace. Among the hospitalized patients reported in the initial Chinese studies, 48% had co-morbidity, particularly diabetes or cardiovascular disease. Covid-19 infection does not appear to be more common in diabetic patients, but infected diabetics have more severe forms.

The prevalence of diabetes is high in Alsace affecting 6.5% of the population against 4.6% in France. Du to health containment measures, asymptomatic diabetic patients can no longer come to the clinic in Hospital for their consultation. However, in the current epidemiological context, maintaining optimal glycemic control is fundamental since some of diabetic patients will have Covid-19 infections. Furthermore, the sedentary lifestyle and snacking linked to the confinement period will contribute to a glycemic imbalance in some patients. Telemedicine, and in particular teleconsultation, which until now has been very uncommon in the management of diabetic patients, represents a very interesting alternative for monitoring these patients and maintaining satisfactory metabolic control during the current period of confinement and Covid-19 epidemic.

Enrollment: 610 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult diabetic patient (type 1,2, MODY, secondary, post transplantation) followed by diabetology consultation at the hospital or by a liberal diabetologist
• Subject affiliated to a social health insurance
• Subject able to understand the objectives of the research
• Subject who expressed his non opposition to the research

Exclusion criteria

• Pregnant woman
• Patients with acute complications (foot ulcer, post stroke, post IDM)
• Cancer or life expectancy of less than 6 months
• Inability to provide informed information to the subject (subject in an emergency, difficulty of understanding for the subject, etc.)
• Subject under judicial protection
• Subject under guardianship or curatorship

Trial design

610 participants in 2 patient groups

Group TC: Diabetic patients followed by Teleconsultation

Description:

Teleconsultation group will be composed of patients for whom the consultation initially scheduled in the presence of the diabetologist has been replaced by a teleconsultation due to the availability of diabetologists whose activity is focused on the management of Covid-19 negative patients.

Treatment:

Other: Teleconsultation either by phone or by computer consultation

Group P: Diabetic patients with conventional follow-up

Description:

Conventional group will be composed of patients for whom the consultation initially scheduled in the presence of the diabetologist was differed by 6 months due to the activity of some diabetologists entirely redirected towards the management of Covid-19 positive patients and not available

Treatment:

Other: care modalities